Extendicare (EXE) Competitors C$10.02 -0.10 (-0.99%) (As of 05:28 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines EXE vs. WELL, DNTL, SIA, DR, KDA, NLH, PHA, BLU, TRIL, and TLRYShould you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include WELL Health Technologies (WELL), dentalcorp (DNTL), Sienna Senior Living (SIA), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), BELLUS Health (BLU), Trillium Therapeutics (TRIL), and Tilray Brands (TLRY). These companies are all part of the "medical" sector. Extendicare vs. WELL Health Technologies dentalcorp Sienna Senior Living Medical Facilities KDA Group Nova Leap Health Premier Health of America BELLUS Health Trillium Therapeutics Tilray Brands WELL Health Technologies (TSE:WELL) and Extendicare (TSE:EXE) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings, dividends and community ranking. Do institutionals & insiders have more ownership in WELL or EXE? 5.6% of WELL Health Technologies shares are held by institutional investors. Comparatively, 19.2% of Extendicare shares are held by institutional investors. 6.8% of WELL Health Technologies shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in WELL or EXE? Extendicare received 111 more outperform votes than WELL Health Technologies when rated by MarketBeat users. However, 58.82% of users gave WELL Health Technologies an outperform vote while only 48.09% of users gave Extendicare an outperform vote. CompanyUnderperformOutperformWELL Health TechnologiesOutperform Votes4058.82% Underperform Votes2841.18% ExtendicareOutperform Votes15148.09% Underperform Votes16351.91% Is WELL or EXE more profitable? WELL Health Technologies has a net margin of 16.15% compared to Extendicare's net margin of 4.28%. Extendicare's return on equity of 60.00% beat WELL Health Technologies' return on equity.Company Net Margins Return on Equity Return on Assets WELL Health Technologies16.15% 18.34% 2.07% Extendicare 4.28%60.00%7.16% Does the media refer more to WELL or EXE? In the previous week, WELL Health Technologies had 14 more articles in the media than Extendicare. MarketBeat recorded 16 mentions for WELL Health Technologies and 2 mentions for Extendicare. WELL Health Technologies' average media sentiment score of 0.80 beat Extendicare's score of 0.26 indicating that WELL Health Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment WELL Health Technologies 3 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Extendicare 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, WELL or EXE? WELL Health Technologies has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Extendicare has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Which has higher earnings and valuation, WELL or EXE? WELL Health Technologies has higher earnings, but lower revenue than Extendicare. WELL Health Technologies is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWELL Health TechnologiesC$910.42M1.91C$147.01MC$0.5712.28ExtendicareC$1.39B0.60C$59.44MC$0.6814.74 Do analysts recommend WELL or EXE? WELL Health Technologies presently has a consensus price target of C$8.28, suggesting a potential upside of 18.25%. Extendicare has a consensus price target of C$10.00, suggesting a potential downside of 0.20%. Given WELL Health Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe WELL Health Technologies is more favorable than Extendicare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WELL Health Technologies 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Extendicare 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 SummaryWELL Health Technologies and Extendicare tied by winning 9 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Get Extendicare News Delivered to You Automatically Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXE vs. The Competition Export to ExcelMetricExtendicareMedical Care Facilities IndustryMedical SectorTSE ExchangeMarket CapC$836.37MC$1.39BC$5.04BC$5.60BDividend Yield5.14%3.79%4.83%5.75%P/E Ratio14.74234.94133.9127.82Price / Sales0.6061.161,148.461,249.66Price / Cash3.2012.9440.5678.85Price / Book7.832.274.753.30Net IncomeC$59.44MC$52.03MC$118.62MC$286.42M7 Day Performance-5.65%-0.29%12.00%-4.00%1 Month PerformanceN/A7.07%12.07%0.33%1 Year Performance37.45%14.57%31.52%35.94% Extendicare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXEExtendicare1.1021 of 5 starsC$10.02-1.0%C$10.00-0.2%+38.6%C$836.37MC$1.39B14.7423,000News CoverageWELLWELL Health Technologies1.5219 of 5 starsC$6.98+2.8%C$7.86+12.6%+80.4%C$1.74BC$910.42M12.33510Analyst ForecastNews CoverageHigh Trading VolumeDNTLdentalcorp1.9891 of 5 starsC$8.44-0.6%C$11.03+30.7%+19.8%C$1.52BC$1.47B-22.959,950SIASienna Senior Living1.5669 of 5 starsC$16.26+0.9%C$18.00+10.7%+42.3%C$1.34BC$844.19M41.3112,000Analyst RevisionNews CoverageDRMedical Facilities0.8281 of 5 starsC$16.01+3.8%C$14.75-7.9%+78.2%C$385.04MC$441.27M14.031,833Insider TradeGap UpKDAKDA GroupN/AC$0.30+9.1%N/A+70.6%C$52.62MC$28.71M-7.503,100High Trading VolumeNLHNova Leap HealthN/AC$0.27-1.9%N/A+8.2%C$22.85MC$25.87M-13.50N/APositive NewsGap UpPHAPremier Health of America2.8241 of 5 starsC$0.13+4.0%C$0.65+400.0%-45.6%C$7.22MC$148.14M-0.59N/AAnalyst RevisionNews CoverageGap UpBLUBELLUS HealthN/AN/AN/AN/AC$2.47BC$16,000.00-20.2974TRILTrillium TherapeuticsN/AC$23.33+0.5%N/AN/AC$2.45BC$43,000.00-34.0633TLRYTilray Brands0.6873 of 5 starsC$1.71flatC$2.95+72.5%-36.2%C$1.50BC$788.94M-3.802,650News Coverage Related Companies and Tools Related Companies WELL Health Technologies Alternatives dentalcorp Alternatives Sienna Senior Living Alternatives Medical Facilities Alternatives KDA Group Alternatives Nova Leap Health Alternatives Premier Health of America Alternatives BELLUS Health Alternatives Trillium Therapeutics Alternatives Tilray Brands Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:EXE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXE Stock Alerts